Loading...
Improving anticancer activity towards colon cancer cells with a new p53‐activating agent
BACKGROUND AND PURPOSE: Impairment of the tumour suppressor p53 pathway is a major event in human cancers, making p53 activation one of the most attractive therapeutic strategies to halt cancer. Here, we have identified a new selective p53 activator and investigated its potential as an anticancer ag...
Na minha lista:
| Udgivet i: | Br J Pharmacol |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6151341/ https://ncbi.nlm.nih.gov/pubmed/30076608 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.14468 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|